EN3-2. Pooled Analysis of Outcomes With Second-Course Pembrolizumab Across 5 Phase 3 Studies of NSCLC von Naoyuki Nogami, Delvys Rodriguez-Abreu, Yi-Long Wu, Michael Boyer, Marina C.Garassino, Tony S.K. Mok, Ying Cheng, Rina Hui, Dariusz M.Kowalski, Andrew G.Robinson, Julie R.Brahmer, Ticiana A.Leal, Gilberto Lopes, Byoung Chul Cho, Silvia Novello, Nir Peled, Gilberto de Castro Jr, Melanie A.Leiby, Diana Chirovsky, Jianxin Lin, M.Catherine Pietanza

Volltext